During the past decade, Bristol - Myers Squibb Co conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Bristol - Myers Squibb Co" are "HIV Infections" (3 trials) and "Chickenpox" (1 trials). Many other conditions were trialed in "Bristol - Myers Squibb Co" in a lesser frequency.

Most popular intervention types in "Bristol - Myers Squibb Co" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Didanosine" (1 trials), "HIVAC-1e" (1 trials), "Smallpox Vaccine" (1 trials), "Sorivudine" (1 trials) and "gp160 Vaccine (MicroGeneSys)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Bristol - Myers Squibb Co" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Bristol - Myers Squibb Co". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Bristol - Myers Squibb Co, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Bristol - Myers Squibb Co, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".